TRIUMPH-4, the first completed Phase 3 trial, showed 28.7% average body weight loss at 68 weeks on retatrutide 12mg versus 2.1% on placebo, as reported by Eli Lilly in December 2025 (peer-reviewed publication pending)
Low levels of selenium can contribute to miscarriage, low semen quality, and poor sperm motility, says Malkoff-Cohen
Waiting too long can mean losing the motivational window when many new mothers feel most ready to act
A clinician should review growth charts, puberty stage, labs, medications, family history, eating patterns, sleep, mental health, and weight-related conditions before discussing medication
As shown in Figure S13 , the ignorable variations further demonstrated the favorable biosafety of the NPs